Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Aprozinate; Aprozinato; Promac; Z 103; ZC 103; Zinc L-carnosine

Latest Information Update: 26 May 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hamari Chemicals
  • Developer SK Chemicals; Zeria
  • Class Antiulcers; Cytoprotectives; Neuropeptides; Organometallic compounds; Small molecules
  • Mechanism of Action Lipid peroxidation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Gastric ulcer
  • Phase III Taste disorders
  • No development reported Gastritis

Most Recent Events

  • 18 Mar 2015 No recent reports on development identified - Registered for Gastritis and Gastric ulcer in South Korea (PO)
  • 05 Feb 2015 Polaprezinc completes phase III development for Taste disorders in Japan
  • 05 Feb 2014 Polaprezinc is still in phase III trials for Taste disorders in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top